|
|
||||||||
Ann Thorac Surg 2003;75:1097-1101
© 2003 The Society of Thoracic Surgeons
a Departments of Cardiothoracic Surgery, Neurosurgery, and Radiation Oncology, Stanford University, Stanford, California, USA
b Departments of Thoracic Surgery and Radiation Oncology, The Cleveland Clinic Medical Foundation, Cleveland, Ohio, USA
Accepted for publication October 29, 2002.
* Address reprint requests to Dr Whyte, Department of Cardiothoracic Surgery, CVRB 205, 300 Pasteur Dr, Stanford, CA94305-5407, USA
e-mail: riwhyte{at}stanford.edu
Presented at the Poster Session of the Thirty-eighth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 2830, 2002.
BACKGROUND: Stereotactic radiosurgery is well established for the treatment of intracranial neoplasms but its use for lung tumors is novel.
METHODS: Twenty-three patients with biopsy-proven lung tumors were recruited into a two-institution, dose-escalation, phase I clinical trial using a frameless stereotactic radiosurgery system (CyberKnife). Fifteen patients had primary lung tumors and 8 had metastatic tumors. The age range was 23 to 87 years (mean, 63 years). After undergoing computed tomographyguided percutaneous placement of two to four small metal fiducials directly into the tumor, patients received 1,500 cGY of radiation in a single fraction using a linear accelerator mounted on a computer-controlled robotic arm. Safety, feasibility, and efficacy were studied.
RESULTS: Nine patients were treated with a breath-holding technique, and 14 with a respiratory-gating, automated, robotic technique. Tumor size ranged from 1 to 5 cm in maximal diameter. There were four complications related to fiducial placement: three pneumothoraces requiring chest tube insertion and one emphysema exacerbation. There were no grade 3 to 5 radiation-related complications. Follow-up ranged from 1 to 26 months (mean, 7.0 months). Radiographic response was scored as complete in 2 patients, partial in 15, stable in 4, and progressive in 2. Four patients died of nontreatment-related causes at 1, 5, 9, and 11 months after radiation.
CONCLUSIONS: Single-fraction stereotactic radiosurgery is safe and feasible for the treatment of selected lung tumors. Additional studies are planned to investigate the optimal radiation dose, best motion-suppression technique, and overall treatment efficacy.
This article has been cited by other articles:
![]() |
T. S. Weiser, K. Hyman, J. Yun, V. Litle, C. Chin, and S. J. Swanson Electromagnetic Navigational Bronchoscopy: A Surgeon's Perspective Ann. Thorac. Surg., February 1, 2008; 85(2): S797 - S801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pennathur, J. D. Luketich, G. Abbas, M. Chen, H. C. Fernando, W. E. Gooding, M. J. Schuchert, S. Gilbert, N. A. Christie, and R. J. Landreneau Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 857 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Anantham, D. Feller-Kopman, L. N. Shanmugham, S. M. Berman, M. M. DeCamp, S. P. Gangadharan, R. Eberhardt, F. Herth, and A. Ernst Electromagnetic Navigation Bronchoscopy-Guided Fiducial Placement for Robotic Stereotactic Radiosurgery of Lung Tumors: A Feasibility Study Chest, September 1, 2007; 132(3): 930 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pennathur, J. D. Luketich, S. Burton, G. Abbas, D. E. Heron, H. C. Fernando, W. E. Gooding, C. Ozhasoglu, J. Ireland, R. J. Landreneau, et al. Stereotactic Radiosurgery for the Treatment of Lung Neoplasm: Initial Experience Ann. Thorac. Surg., May 1, 2007; 83(5): 1820 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Timmerman In Reply J. Clin. Oncol., February 1, 2007; 25(4): 465 - 465. [Full Text] [PDF] |
||||
![]() |
T. E. Stinchcombe, D. Fried, D. E. Morris, and M. A. Socinski Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer Oncologist, July 1, 2006; 11(7): 809 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Pennington The Impact of New Technology on Cardiothoracic Surgical Practice Ann. Thorac. Surg., January 1, 2006; 81(1): 10 - 18. [Full Text] [PDF] |
||||
![]() |
B. Jeremic, B. Milicic, L. Acimovic, and S. Milisavljevic Concurrent Hyperfractionated Radiotherapy and Low-Dose Daily Carboplatin/Paclitaxel in Patients With Early-Stage (I/II) Non-Small-Cell Lung Cancer: Long-Term Results of a Phase II Study J. Clin. Oncol., October 1, 2005; 23(28): 6873 - 6880. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ricke, P. Wust, G. Wieners, S. Hengst, M. Pech, E. L. Hanninen, and R. Felix CT-Guided Interstitial Single-Fraction Brachytherapy of Lung Tumors: Phase I Results of a Novel Technique Chest, June 1, 2005; 127(6): 2237 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Fernando, A. D. Hoyos, R. J. Landreneau, S. Gilbert, W. E. Gooding, P. O. Buenaventura, N. A. Christie, C. Belani, and J. D. Luketich Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 639 - 644. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |